CytRx Hopes Bafetinib Will Soon Be Approved For Use In Multiple Myeloma Patients

I ran a story about Bafetinib on MyelomaNews.com yesterday:  CYTRX : CytRx's Bafetinib Demonstrates Ability to Prevent Cancer-Related Bone Loss Interesting that the company chose to quote Dr. Berenson in their press release.  You remember ...